Coloplast has inaugurated its largest manufacturing site to date, a two-floor 50,000 m2 facility in Felgueiras, Portugal, expanding the company’s production capacity to meet growing global demand for continence care products, while supporting the company’s long-term ambition of helping four million people worldwide.
Coloplast has a global manufacturing network with high volume production sites in Hungary, China, and Costa Rica, specialised production in the US, France, Germany, Sweden, and Iceland, as well as an innovation and pilot plant in Denmark. With the new site in Portugal operational, Coloplast has sufficient production capacity to reach its targets within the current 2030 strategy period without constructing additional manufacturing sites.
Our new manufacturing site is an important milestone in our company’s mission to help those with intimate healthcare needs. We have chosen Portugal as the destination for several reasons. Most importantly, Portugal has a qualified and highly trained labour force as well as a competitive cost level. It is also important that Portugal is in Europe, where we serve most of our users today and where more and more people will be needing our products in the years to come. This destination allows us to diversify our manufacturing footprint in Europe, which is currently concentrated in Hungary. Finally, Portugal has a large supply of renewable electricity as well as an ambition to become carbon neutral by 2045, says Executive Vice President, Global Operations, Allan Rasmussen.
AICEP – The Portuguese Trade & Investment Agency – has played an active role in helping Coloplast establish its site in Felgueiras.
Coloplast’s decision to establish its largest industrial hub in Portugal is a strong vote of confidence in our country’s ability to attract and deliver strategic industrial investments. This is particularly significant in the medical devices sector, where advanced manufacturing, innovation, highly skilled talent and the highest quality standards are critical to success. This investment reinforces Portugal’s position as a competitive destination for high-value industrial projects and demonstrates our capacity to support their long-term growth. AICEP is proud to have supported Coloplast throughout this journey. We look forward to seeing this investment create skilled jobs, strengthen Portugal’s industrial ecosystem and contribute to the company’s continued international growth, says Ana Casaca, President of AICEP.
With the new site in Portugal operational, Coloplast has sufficient production capacity to reach its targets within the current 2030 strategy period without constructing additional manufacturing sites.
